HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 118 filers reported holding HOMOLOGY MEDICINES INC in Q2 2021. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $138,625 | -13.9% | 118,483 | -34.9% | 0.00% | – |
Q2 2023 | $161,089 | +74478.2% | 182,021 | -13.2% | 0.00% | – |
Q1 2023 | $216 | -28.9% | 209,687 | -13.0% | 0.00% | – |
Q4 2022 | $304 | -100.0% | 241,004 | -47.5% | 0.00% | – |
Q3 2022 | $740,000 | -48.0% | 459,485 | -36.4% | 0.00% | -100.0% |
Q2 2022 | $1,422,000 | +86.9% | 721,964 | +245.2% | 0.00% | – |
Q4 2021 | $761,000 | -23.6% | 209,167 | +65.2% | 0.00% | -100.0% |
Q3 2021 | $996,000 | -52.4% | 126,616 | -56.0% | 0.00% | 0.0% |
Q2 2021 | $2,093,000 | -10.5% | 287,893 | +15.9% | 0.00% | -50.0% |
Q1 2021 | $2,338,000 | +25.5% | 248,474 | +50.6% | 0.00% | +100.0% |
Q4 2020 | $1,863,000 | +32.2% | 165,006 | +25.3% | 0.00% | -50.0% |
Q3 2020 | $1,409,000 | -54.1% | 131,706 | -34.8% | 0.00% | -50.0% |
Q2 2020 | $3,068,000 | +692.8% | 201,980 | +711.6% | 0.00% | +300.0% |
Q1 2020 | $387,000 | -67.1% | 24,888 | -56.2% | 0.00% | 0.0% |
Q4 2019 | $1,177,000 | +189.9% | 56,863 | +174.1% | 0.00% | 0.0% |
Q2 2019 | $406,000 | -76.1% | 20,745 | -77.2% | 0.00% | -50.0% |
Q1 2018 | $1,700,000 | – | 90,923 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 4,535,919 | $51,211,000 | 17.25% |
Vida Ventures Advisors, LLC | 770,845 | $8,703,000 | 1.79% |
AAF Wealth Management, LLC | 59,790 | $675,000 | 0.61% |
Vivo Capital, LLC | 853,143 | $9,632,000 | 0.43% |
Bellevue Group AG | 1,737,122 | $19,612,000 | 0.22% |
PREMIER ASSET MANAGEMENT LLC | 77,108 | $871,000 | 0.18% |
Temasek Holdings (Private) Ltd | 3,220,293 | $36,357,000 | 0.16% |
American Investment Services, Inc. | 36,955 | $417,000 | 0.13% |
Virtus ETF Advisers LLC | 24,646 | $278,000 | 0.12% |
FIRST MIDWEST BANK TRUST DIVISION | 65,983 | $745,000 | 0.11% |